Silver Nanoparticles as Antimicrobial Agents in Veterinary Medicine: Current Applications and Future Perspectives

Silver nanoparticles (AgNPs) have gained significant attention in veterinary medicine due to their antimicrobial properties and potential therapeutic applications. Silver has long been recognized for its ability to combat a wide range of pathogens, and when engineered at the nanoscale, silver’s surface area and reactivity are greatly enhanced, making it highly effective against bacteria, viruses, and fungi. This narrative review aimed to summarize the evidence on the antimicrobial properties of AgNPs and their current and potential clinical applications in veterinary medicine. The antimicrobial action of AgNPs involves several mechanisms, including, among others, the release of silver ions, disruption of cell membranes and envelopes, induction of oxidative stress, inhibition of pathogens’ replication, and DNA damage. Their size, shape, surface charge, and concentration influence their efficacy against bacteria, viruses, and fungi. As a result, the use of AgNPs has been explored in animals for infection prevention and treatment in some areas, such as wound care, coating of surgical implants, animal reproduction, and airway infections. They have also shown promise in preventing biofilm formation, a major challenge in treating chronic bacterial infections. Additionally, AgNPs have been studied for their potential use in animal feed as a supplement to enhance animal health and growth. Research suggested that AgNPs could stimulate immune responses and improve the gut microbiota of livestock, potentially reducing the need for antibiotics in animal husbandry. Despite their promising applications, further research is necessary to fully understand the safety, efficacy, and long-term effects of AgNPs on animals, humans, and the environment.